Improving Biopharma R&D efficiency a mixed blessing for CROs
Improving efficiency in biopharma research is a “mixed blessing” for contract research organisations (CROs), according to Wells Fargo.
Archives for September 5, 2012
Is the male contraceptive pill coming soon?
A male version of the contraceptive pill could be just around the corner, according to researchers at Texas A&M University.
update
FDA criticizes DPT's efforts to fix sterility problems
US CDMO DPT Labs has not done enough to investigate sterility failures observed during a March inspection according to the Food and Drug Administration (FDA) which wants a ‘comprehensive evaluation’ of sterile drug operations.
Codexis cuts will affect pharma business
Codexis says job cuts will affect pharma business, but is confident that Merck & Co deal and enzyme tech IP will drive growth.
HIV "test and treat" in South Africa a no-go for the WHO
The WHO has rubbished claims by the UCLA that it is planning launch a “test and treat” strategy in South Africa.
Wuxi enters Ab sector in partnership with transgenic rat developer OMT
WuXi PharmaTech has formed an antibody discovery partnership with US transgenic animals firm Open Monoclonal Technology (OMT).
News from RSP, CMC Biologics and the NIH – People on the move
Outsourcing-Pharma.com presents its weekly round-up of the latest career changes in the pharmaceutical industry, including news from RSP, CMC Biologics and the NIH.